These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26057142)

  • 1. Digoxin-Specific Antibody Fragment Dosing: A Case Series.
    Chhabra N; Valento M; Bryant SM; Aks SE
    Am J Ther; 2016; 23(6):e1597-e1601. PubMed ID: 26057142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Digoxin-Specific Fab Fragment Dosages in Digoxin Poisoning.
    Nordt SP; Clark RF; Machado C; Cantrell FL
    Am J Ther; 2016; 23(1):e63-7. PubMed ID: 25379735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning.
    Lapostolle F; Borron SW; Verdier C; Taboulet P; Guerrier G; Adnet F; Clemessy JL; Bismuth C; Baud FJ
    Crit Care Med; 2008 Nov; 36(11):3014-8. PubMed ID: 18824911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
    Chan BS; Isbister GK; O'Leary M; Chiew A; Buckley NA
    Clin Toxicol (Phila); 2016 Jul; 54(6):488-94. PubMed ID: 27118413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of clinical experience with digoxin immune Fab (ovine).
    Smith TW
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):1-6; discussion 33-4. PubMed ID: 1997014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin-specific antibody fragments: how much and when?
    Bateman DN
    Toxicol Rev; 2004; 23(3):135-43. PubMed ID: 15862081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency step-by-step specific immunotherapy in severe digoxin poisoning: an observational cohort study.
    Bilbault P; Oubaassine R; Rahmani H; Lavaux T; Castelain V; Sauder P; Schneider F
    Eur J Emerg Med; 2009 Jun; 16(3):145-9. PubMed ID: 19262393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.
    Lapostolle F; Borron SW; Verdier C; Arnaud F; Couvreur J; Mégarbane B; Baud F; Adnet F
    Intensive Care Med; 2008 Aug; 34(8):1448-53. PubMed ID: 18389220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculated decisions: DigiFab® (Digibind®) Dosing for Digoxin Poisoning.
    Lucyk S
    Emerg Med Pract; 2020 Sep; 22(Suppl 9):CD1-CD3. PubMed ID: 33476509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4).
    Chan BS; Isbister GK; Page CB; Isoardi KZ; Chiew AL; Kirby KA; Buckley NA
    Clin Toxicol (Phila); 2019 Jul; 57(7):638-643. PubMed ID: 30585517
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. (ATOM-6).
    Chan BS; Isbister GK; Chiew A; Isoardi K; Buckley NA
    Clin Toxicol (Phila); 2022 Apr; 60(4):433-439. PubMed ID: 34424803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasma kinetics of digoxin-specific Fab fragments and digoxin in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1991 Nov; 43(11):807-10. PubMed ID: 1686913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin toxicity treated with Digibind.
    Schakenbach L; Arft P
    Crit Care Nurse; 1989 May; 9(5):16-22. PubMed ID: 2805742
    [No Abstract]   [Full Text] [Related]  

  • 17. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
    Milani L; Bizzaro N; Sanson A
    G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free and total digoxin in serum during treatment of acute digoxin poisoning with Fab fragments: case study.
    Eyer F; Steimer W; Müller C; Zilker T
    Am J Crit Care; 2010 Jul; 19(4):391-87. PubMed ID: 19875723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fab fragments in the treatment of digoxin overdose: pediatric considerations.
    Fazio A
    South Med J; 1987 Dec; 80(12):1553-6. PubMed ID: 2892273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and successful management of suicidal digoxin toxicity without use of digoxin-specific antibody (Fab) fragments--is it possible?
    Sanaei-Zadeh H; Valian Z; Zamani N; Farajidana H; Mostafazadeh B
    Trop Doct; 2011 Apr; 41(2):108-10. PubMed ID: 21262953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.